-
Non-invasive gut mucus analysis to functionally characterize the effects of GEMM and afford new IBD biomarkers.
Read MoreInflammatory bowel disease (IBD) affects ca. 300,000 Canadians with an annual burden of $1.3 billion in associated with treatments, medications, and lost…
-
Robert Bruce
Primary Investigator
-
